In conclusion, we report that down regulation of OMA1 expression in metastatic breast cancer cells and the subsequent activation of UPRmt could form the basis for promoting malignancy and metastatic progression of breast adenocarcinoma. The gene discussed is OMA1; the disease is breast adenocarcinoma.